Atom Investors LP Has $4.58 Million Stock Position in TriMas Co. (NASDAQ:TRS)

Atom Investors LP boosted its stake in TriMas Co. (NASDAQ:TRS - Free Report) by 62.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 179,328 shares of the industrial products company's stock after purchasing an additional 68,608 shares during the quarter. Atom Investors LP owned about 0.44% of TriMas worth $4,578,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Innealta Capital LLC acquired a new position in shares of TriMas during the 2nd quarter worth $26,000. Aristides Capital LLC acquired a new position in TriMas during the second quarter worth about $245,000. Intech Investment Management LLC bought a new position in shares of TriMas in the third quarter worth about $269,000. Paloma Partners Management Co acquired a new stake in shares of TriMas in the 3rd quarter valued at approximately $293,000. Finally, Algert Global LLC grew its holdings in shares of TriMas by 4.2% during the 2nd quarter. Algert Global LLC now owns 15,779 shares of the industrial products company's stock valued at $403,000 after purchasing an additional 639 shares during the last quarter. Institutional investors own 99.42% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on TRS shares. BWS Financial reaffirmed a "buy" rating and set a $40.00 target price on shares of TriMas in a research note on Tuesday, November 5th. StockNews.com raised TriMas from a "sell" rating to a "hold" rating in a report on Wednesday, November 13th.

TriMas Trading Up 0.6 %

NASDAQ:TRS traded up $0.17 during trading hours on Monday, hitting $26.59. 161,254 shares of the company were exchanged, compared to its average volume of 267,750. The company has a fifty day simple moving average of $26.42 and a 200 day simple moving average of $25.84. TriMas Co. has a one year low of $22.45 and a one year high of $28.51. The stock has a market capitalization of $1.08 billion, a price-to-earnings ratio of 41.28 and a beta of 0.66. The company has a current ratio of 2.83, a quick ratio of 1.44 and a debt-to-equity ratio of 0.60.

TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). TriMas had a net margin of 2.93% and a return on equity of 9.21%. The firm had revenue of $229.36 million during the quarter, compared to the consensus estimate of $239.33 million. During the same period in the prior year, the company posted $0.57 earnings per share. The company's revenue for the quarter was down 2.5% compared to the same quarter last year. Sell-side analysts expect that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, November 12th. Stockholders of record on Tuesday, November 5th were paid a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date of this dividend was Tuesday, November 5th. TriMas's dividend payout ratio is 25.00%.

TriMas Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.